Pfizer Inc. (PFE)
NYSE: PFE · Real-Time Price · USD
24.54
-0.80 (-3.16%)
At close: Apr 1, 2025, 4:00 PM
24.61
+0.07 (0.29%)
After-hours: Apr 1, 2025, 7:59 PM EDT
Pfizer Market Cap
Pfizer has a market cap or net worth of $139.18 billion as of April 1, 2025. Its market cap has decreased by -12.38% in one year.
Market Cap
139.18B
Enterprise Value
186.12B
1-Year Change
-12.38%
Ranking
Category
Stock Price
$24.54
Market Cap Chart
Since December 1, 1998, Pfizer's market cap has decreased from $144.06B to $139.18B, a decrease of -3.39%. That is a compound annual growth rate of -0.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2025 | 143.61B | -4.48% |
| Dec 31, 2024 | 150.35B | -7.51% |
| Dec 29, 2023 | 162.56B | -43.48% |
| Dec 30, 2022 | 287.63B | -13.22% |
| Dec 31, 2021 | 331.44B | 61.99% |
| Dec 31, 2020 | 204.60B | -5.64% |
| Dec 31, 2019 | 216.83B | -14.07% |
| Dec 31, 2018 | 252.32B | 16.87% |
| Dec 29, 2017 | 215.90B | 9.54% |
| Dec 30, 2016 | 197.10B | -1.09% |
| Dec 31, 2015 | 199.26B | 1.53% |
| Dec 31, 2014 | 196.27B | -1.13% |
| Dec 31, 2013 | 198.52B | 7.51% |
| Dec 31, 2012 | 184.65B | 11.00% |
| Dec 30, 2011 | 166.35B | 18.60% |
| Dec 31, 2010 | 140.25B | -4.45% |
| Dec 31, 2009 | 146.78B | 22.92% |
| Dec 31, 2008 | 119.42B | -23.08% |
| Dec 31, 2007 | 155.24B | -16.87% |
| Dec 29, 2006 | 186.75B | 8.64% |
| Dec 30, 2005 | 171.90B | -15.11% |
| Dec 31, 2004 | 202.51B | -24.89% |
| Dec 31, 2003 | 269.62B | 43.13% |
| Dec 31, 2002 | 188.38B | -24.81% |
| Dec 31, 2001 | 250.53B | -13.68% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |